These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 35408825)
1. Therapeutic Applications of Adeno-Associated Virus (AAV) Gene Transfer of HLA-G in the Eye. Gilger BC; Hirsch ML Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35408825 [TBL] [Abstract][Full Text] [Related]
2. AAV-mediated expression of HLA-G1/5 reduces severity of experimental autoimmune uveitis. Crabtree E; Song L; Llanga T; Bower JJ; Cullen M; Salmon JH; Hirsch ML; Gilger BC Sci Rep; 2019 Dec; 9(1):19864. PubMed ID: 31882729 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor-B gene transfer exacerbates retinal and choroidal neovascularization and vasopermeability without promoting inflammation. Zhong X; Huang H; Shen J; Zacchigna S; Zentilin L; Giacca M; Vinores SA Mol Vis; 2011 Feb; 17():492-507. PubMed ID: 21364963 [TBL] [Abstract][Full Text] [Related]
4. AAV vector-meditated expression of HLA-G reduces injury-induced corneal vascularization, immune cell infiltration, and fibrosis. Hirsch ML; Conatser LM; Smith SM; Salmon JH; Wu J; Buglak NE; Davis R; Gilger BC Sci Rep; 2017 Dec; 7(1):17840. PubMed ID: 29259248 [TBL] [Abstract][Full Text] [Related]
5. Intraocular route of AAV2 vector administration defines humoral immune response and therapeutic potential. Li Q; Miller R; Han PY; Pang J; Dinculescu A; Chiodo V; Hauswirth WW Mol Vis; 2008 Sep; 14():1760-9. PubMed ID: 18836574 [TBL] [Abstract][Full Text] [Related]
6. Preparation and Administration of Adeno-associated Virus Vectors for Corneal Gene Delivery. Song L; Bower JJ; Hirsch ML Methods Mol Biol; 2020; 2145():77-102. PubMed ID: 32542602 [TBL] [Abstract][Full Text] [Related]
8. A novel bispecific molecule delivered by recombinant AAV2 suppresses ocular inflammation and choroidal neovascularization. Li Y; Zhu P; Verma A; Prasad T; Deng H; Yu D; Li Q J Cell Mol Med; 2017 Aug; 21(8):1555-1571. PubMed ID: 28332318 [TBL] [Abstract][Full Text] [Related]
9. Serotype survey of AAV gene delivery via subconjunctival injection in mice. Song L; Llanga T; Conatser LM; Zaric V; Gilger BC; Hirsch ML Gene Ther; 2018 Sep; 25(6):402-414. PubMed ID: 30072815 [TBL] [Abstract][Full Text] [Related]
10. Gene delivery of a viral anti-inflammatory protein to combat ocular inflammation. Ildefonso CJ; Jaime H; Rahman MM; Li Q; Boye SE; Hauswirth WW; Lucas AR; McFadden G; Lewin AS Hum Gene Ther; 2015 Jan; 26(1):59-68. PubMed ID: 25420215 [TBL] [Abstract][Full Text] [Related]
11. Development of gene therapy for treatment of age-related macular degeneration. Askou AL Acta Ophthalmol; 2014 Jul; 92 Thesis3():1-38. PubMed ID: 24953666 [TBL] [Abstract][Full Text] [Related]
12. AAV-mediated gene supply for treatment of degenerative and neovascular retinal diseases. Colella P; Auricchio A Curr Gene Ther; 2010 Oct; 10(5):371-80. PubMed ID: 20712580 [TBL] [Abstract][Full Text] [Related]
13. AAV-mediated expression of HLA-G for the prevention of experimental ocular graft vs. host disease. Nilles JP; Roberts D; Salmon JH; Song L; O'Dea C; Marjoram LT; Bower JJ; Hirsch ML; Gilger BC Mol Ther Methods Clin Dev; 2023 Jun; 29():227-235. PubMed ID: 37090476 [TBL] [Abstract][Full Text] [Related]
14. AAV-mediated gene delivery of the calreticulin anti-angiogenic domain inhibits ocular neovascularization. Tu L; Wang JH; Barathi VA; Prea SM; He Z; Lee JH; Bender J; King AE; Logan GJ; Alexander IE; Bee YS; Tai MH; Dusting GJ; Bui BV; Zhong J; Liu GS Angiogenesis; 2018 Feb; 21(1):95-109. PubMed ID: 29318471 [TBL] [Abstract][Full Text] [Related]
15. Antibody neutralization poses a barrier to intravitreal adeno-associated viral vector gene delivery to non-human primates. Kotterman MA; Yin L; Strazzeri JM; Flannery JG; Merigan WH; Schaffer DV Gene Ther; 2015 Feb; 22(2):116-26. PubMed ID: 25503696 [TBL] [Abstract][Full Text] [Related]
16. AAV-mediated gene transfer of pigment epithelium-derived factor inhibits choroidal neovascularization. Mori K; Gehlbach P; Yamamoto S; Duh E; Zack DJ; Li Q; Berns KI; Raisler BJ; Hauswirth WW; Campochiaro PA Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1994-2000. PubMed ID: 12037010 [TBL] [Abstract][Full Text] [Related]
17. Characterization of Gene Therapy Associated Uveitis Following Intravitreal Adeno-Associated Virus Injection in Mice. Tummala G; Crain A; Rowlan J; Pepple KL Invest Ophthalmol Vis Sci; 2021 Feb; 62(2):41. PubMed ID: 33630023 [TBL] [Abstract][Full Text] [Related]
18. Ocular Inflammatory Response to Intravitreal Injection of Adeno-Associated Virus Vector: Relative Contribution of Genome and Capsid. Timmers AM; Newmark JA; Turunen HT; Farivar T; Liu J; Song C; Ye GJ; Pennock S; Gaskin C; Knop DR; Shearman MS Hum Gene Ther; 2020 Jan; 31(1-2):80-89. PubMed ID: 31544533 [TBL] [Abstract][Full Text] [Related]
19. AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies. Castro BFM; Steel JC; Layton CJ BioDrugs; 2024 Jan; 38(1):73-93. PubMed ID: 37878215 [TBL] [Abstract][Full Text] [Related]